subgroup
of
drug)
→
ReceivesAction
→
approved in 2017
Typicality: | 0.280 |
Saliency: | 0.071 |
new drug → be approved in → 2017 | 4 |
negative | neutral | positive |
0.013 | 0.511 | 0.476 |
Raw frequency | 4 |
Normalized frequency | 0.071 |
Modifier score | 0.500 |
Perplexity | 247.173 |